Cystadenocarcinoma, Mucinous - 25 Studies Found Withdrawn : Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy : Fatigue Malignant Ovarian Mixed Epithelial Tumor Neuropath : 2011-12-14 : Dietary Supplement: Acetyl-L-Carnitine Hydrochloride Active, not recruiting : Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy : Cognitive Side Effects of Cancer Therapy Malignant Ovarian Epithelial Tumor Procedure: Cognitive Assessment Active, not recruiting : Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer : Fallopian Tube Clear Cell Adenocarcinoma Fallopian Tube Endometrioid Adenocarcinoma : 2010-02-23 : Drug: Bortezomib Given IP Completed : Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer : Chemotherapeutic Agent Toxicity Endometrial Adenocarcinoma : 2008-12-20 : Drug: Paclitaxel Given IV or i Completed : Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) : Brenner Tumor Fallopian Tube Cancer Ovarian Carcinosarcoma : 2004-06-10 : Drug: carboplatin Given intrap <<< Previous